On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


Embracing Patient-Centric Healthcare: The 4th Chief Patient Officer Summit

The upcoming 4th Chief Patient Officer Summit, hosted by Dynamic Global Events, will convene on July 15-16, 2024, in Boston, MA. Professionals in Patient Affairs, Clinical Trials, Patient Communications, Patient Advocacy, and related industry areas are invited to attend at the Hilton Boston Back Bay.

The summit, which will include panel presentations, two concurrent workshops, and networking opportunities, will gather top leaders from the healthcare industry to focus on patient engagement and advocacy.

As the most extensive forum to focus on the role of the Chief Patient Officer, 44 distinguished speakers will share their insight to explore solutions to the largest challenges.

The summit will feature distinguished speakers including:

  • Dr. Beth Frates, President of the American College of Lifestyle Medicine
  • Ifeyinwa Osunkwo, MD, Chief Patient Officer at Novo Nordisk Rare Disease
  • Tricia Mullins, Executive Director, Global Head, Early Patient Engagement & Professional Societies at Beigene
  • Wendy Erler, Vice President, Global Head, Patient Experience, Patient Advocacy & Patient Caregiver Insights at AstraZeneca

View the agenda to meet the full speaking faculty.

Attendees will explore key topics like regulatory strategies, health equity, and patient-centric innovations, fostering a collaborative environment to enhance patient care across the industry.

For conference and registration details, visit www.dgevents.com/event/chief-patient-officer-summit/

*Use discount code IBN2024 to save 15% off*

From Our Blog

Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

July 23, 2024

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), is thrilled to welcome four seasoned professionals to its executive team. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, said the company was delighted to have […]

Rotate your device 90° to view site.